Singapore, Nov. 12 -- Toxys, a biotechnology company specialising in innovative in vitro toxicology solutions, and Charles River Laboratories announced an expanded collaboration to broaden access to ToxTracker(R) and ReproTracker(R), two New Approach Methodologies for genotoxicity and developmental toxicity assessment. Under a licensing agreement, Charles River will offer ToxTracker from its Den Bosch facility; under a subcontracting agreement, it will offer ReproTracker, with testing performed at Toxys.

The partnership combines Toxys' mechanistic assay platforms with Charles River's global safety assessment capabilities to support more predictive, human-relevant decision-making across pharmaceutical, chemical, agrochemical, and consumer...